Fulgent Genetics (FLGT) FCF Margin (2015 - 2026)
Fulgent Genetics (FLGT) posted FCF Margin of 32.34% for Q2 2026, down 1314.09% sequentially from 2.66% in Q1 2026, and up 1289.0% YoY from 2.33% in Q2 2025.
Fulgent Genetics (FLGT) FCF Margin (2015 - 2026) Analysis & Trends
Fulgent Genetics has reported FCF Margin for 12 years, with the latest figure at 32.34% in Q2 2026.
- Quarterly FCF Margin rose 1289.0% year-over-year to 32.34% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 43.07% (down 2329.0% YoY) and the FY2025 annual result came in at 38.49%, down 3170.0% from the prior year.
- FCF Margin retreated to 32.34% in Q2 2026 per FLGT's latest filing, from 2.66% in the prior quarter.
- Over five years, FCF Margin peaked at 57.16% in Q1 2022 and troughed at 20780.75% in Q4 2025.
- A 5-year average of 1154.1% and a median of 3.82% in 2026 frame the typical range for FCF Margin.
- The widest YoY moves for FCF Margin: up 5486 bps in 2025, down 2080862 bps in 2025.
- Over 5 years, FCF Margin stood at 34.07% in 2022, then slumped by 51 bps to 16.77% in 2023, then soared by 66 bps to 27.87% in 2024, then plunged by 74666 bps to 20780.75% in 2025, then surged by 100 bps to 32.34% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 32.34%, 2.66%, and 20780.75% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 13.97% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 20.19% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -1.15% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 10.95% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 8.24% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 26.51% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 13.89% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 27.51% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.41% |
| 10 | Fulgent Genetics | 557.44 Mn | 300.41 Mn | 25.68 Mn | -32.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32.34% |
| Mar 31, 2026 | 2.66% |
| Dec 31, 2025 | -20,780.75% |
| Sep 30, 2025 | 6.02% |
| Jun 30, 2025 | -45.23% |
| Mar 31, 2025 | -12.45% |
| Dec 31, 2024 | 27.87% |
| Sep 30, 2024 | -48.85% |
| Jun 30, 2024 | -12.19% |
| Mar 31, 2024 | 4.98% |
| Dec 31, 2023 | 16.77% |
| Sep 30, 2023 | 6.28% |
| Jun 30, 2023 | -3.55% |
| Mar 31, 2023 | -15.02% |
| Dec 31, 2022 | 34.07% |
| Sep 30, 2022 | 14.52% |
| Jun 30, 2022 | 6.28% |
| Mar 31, 2022 | 57.16% |
| Dec 31, 2021 | 28.25% |
| Sep 30, 2021 | 65.30% |